Looks like you’re on the UK site. Choose another location to see content specific to your location

Home Industry News Pfizer sets up new partnership model for early-stage academic research

Pfizer sets up new partnership model for early-stage academic research

9th January 2018

Pfizer has announced the establishment of the new Innovative Target Exploration Network (ITEN), a new early-stage partnership model to facilitate better collaborative relationships with academic institutions.

The new ITEN model is designed to help Pfizer and its partner institutions share ideas that will bring cutting-edge academic research together with the translational capabilities offered by industry businesses, supported by a wide network of resources and relationships.

The UK's University of Cambridge and the University of Oxford will be the first to participate in the ITEN model, while the University of Texas Southwestern is the first US institution to take part, with Pfizer seeking other universities to be get involved.

Through this initiative, Pfizer aims to identify research projects that have the potential to deliver novel therapeutic targets and mechanisms of action to underpin future drug discovery in core areas of interest to the company.

Uwe Schoenbeck, senior vice-president and chief scientific officer for external science and innovation at Pfizer, said: "By establishing relationships with researchers early in the research and development process, we believe the ITEN model will better position us to identify potentially promising research projects."

With over 20 years of experience within the pharmaceutical market, we at Zenopa have the knowledge, skills and expertise to help find the right job for you. To find out more about the current pharmaceutical roles we have available, you can search for the latest job roles, register your details, or contact the team today.


We currently have 5 jobs available in Pharmacy industry, find your perfect one now.

Stay informed

Receive the latest industry news, Tips
and straight to your inbox.